COVID-19 is significantly impacting patient organisations’ ability to undertake their critical work as funds and resources are diverted to COVID-19 initiatives
As these patient organisations are altering their essential services to provide greater proactive outreach to patients, revenues from donations and community initiatives have slowed, or even stopped
Novartis Australia has rolled out funding for COVID-19 related programs, support for mental health and stepped up its promotion of partner patient organisation campaigns
Novartis in Australia and New Zealand continues to closely monitor and respond to the coronavirus (COVID-19) situation. Our priority is to ensure the health and safety of our people, patients, and healthcare professionals.